# StAtins for Venous Event Reduction in Patients With Venous Thromboembolism Pilot Study

> **NCT02679664** · PHASE2 · UNKNOWN · sponsor: **Ottawa Hospital Research Institute** · enrollment: 312 (actual)

## Conditions studied

- Venous Thromboembolism

## Interventions

- **DRUG:** Rosuvastatin

## Key facts

- **NCT ID:** NCT02679664
- **Lead sponsor:** Ottawa Hospital Research Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-11
- **Primary completion:** 2020-01-13
- **Final completion:** 2020-07
- **Target enrollment:** 312 (ACTUAL)
- **Last updated:** 2020-02-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02679664

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02679664, "StAtins for Venous Event Reduction in Patients With Venous Thromboembolism Pilot Study". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT02679664. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*